NPR · 7 hours ago

How an Mrna Vaccine Helped One Woman with Pancreatic Cancer

Seven years ago, Donna Gustafson became the world's first person to receive an mRNA vaccine designed to treat pancreatic cancer - a disease that kills most of its patients within months - and today, at 72, she is hiking, skydiving, and watching grandchildren grow. The science behind her survival is extraordinary: a personalized vaccine built from samples of her own tumor, training her immune system to recognize and destroy cancerous cells, producing what researchers measured as a "10,000-fold increase" in cancer-attacking cells that has held steady for years beyond her final dose. But woven through the clinical details is something quieter - the way a brush with death reshaped how she and her husband move through ordinary time. "We live so much more for the day now," Ed Gustafson says, looking at his wife. What this story reveals is not just a medical breakthrough, but the way that being offered "some type of hope" - and choosing to reach toward it - can return a person not merely to life, but to a fuller version of it.